2024 annual financial data
Grace Therapeutics 2024 Operating margin
Grace Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -17,440,292 USD and net income was -17,441,649 USD.
Operating cash flow was -12,333,000 USD.
Get free Grace Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,440,292 USD
- Net income
- -17,441,649 USD
- Operating cash flow
- -12,333,000 USD